Table 1.
Patient Demographics
| Variable | All Patients (N = 274) |
|---|---|
| Age, y, median (range) | 59 (15 d–95 y) |
| Race | |
| Caucasian | 183 (66.7) |
| African American | 82 (30) |
| Asian | 4 (1.5) |
| Indian | 4 (1.5) |
| Other | 1 (0.3) |
| Male sex | 134 (48.9) |
| Underlying diseasea | |
| Hematopoietic stem cell transplant | 23 (8.4) |
| Solid organ transplant | 26 (9.5) |
| Acute leukemia/lymphoma | 28 (10.2) |
| Solid organ malignancyb | 38 (13.8) |
| Other immunosuppressionc | 25 (9.1) |
| Major surgery within 30 d | 106 (38.7) |
| Renal dysfunction | |
| End-stage renal disease | 31 (11.3) |
| Acute renal failure | 48 (17.5) |
| Liver disease | 21 (7.7) |
| Extremely low birth weight infant (<1 kg) | 2 (0.7) |
| Neutropenia (total white blood cell count <500 cells/μL)d | 22 (8.0) |
| Days of hospitalization at time of candidemia, mean (range)d | 18.2 (−4 to 165) |
Data are presented as No. (%) unless otherwise specified.
a Subjects may have had >1 underlying disease.
b Received chemotherapy within the prior 3 months.
c Steroids (>15 mg prednisone or equivalent) daily for >30 days, diabetes, congenital immunosuppressive condition, human immunodeficiency virus/AIDS.
d Based on the initial (index) positive blood culture; neutropenic status is unknown for 4 patients.